ASCO Annual Meeting

Pediatric Neuroblastoma Survivors Face Task Efficiency, Emotional Regulation Impairments

July 9th 2019, 12:00am

Article

Long-term survivors of pediatric neuroblastoma may be at an increased risk for neurocognitive impairment – in particular, due to age at diagnosis and the type of treatment received.

App Helps Move Glioblastoma From 'Terminal to Treatable, Powered by Patients' Input

July 8th 2019, 4:47pm

Article

A glioblastoma (GBM)-specific app, called OurBrainBank, efficiently collected patients’ symptoms – offering many hope for future research, according to founder Jessica Morris.

Lung Cancer Stigmas Affect Patients Psychosocially, Lead to Worse Health Outcomes

July 5th 2019, 5:00pm

Video

Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.

Adcetris Is a 'Good Treatment' for Patients With Advanced Hodgkin Lymphoma

July 4th 2019, 5:00pm

Article

A lymphoma expert discusses the side effect profile and follow-up data from the ECHELON-1 clinical trial.

Tumor Mutation Burden May Be Predictive of Depression in Patients With Lung Cancer

July 3rd 2019, 9:00pm

Video

Tumor mutation burden may be an independent predictor of developing depression in patients with lung cancer, according to Dr. Daniel McFarland.

Cell Therapies May Help Overcome Drug Resistance in Patients With Mantle Cell Lymphoma

July 1st 2019, 7:00pm

Video

Breakthroughs such as CAR-T cell therapy in the treatment of mantle cell lymphoma could help patients overcome drug resistance and ultimately live longer, according to Dr. Michael Wang.

Telemedicine: A Growing Opportunity in Oncology

June 28th 2019, 5:00pm

Article

The growing use of telecommunication and technology to provide health care – or telemedicine – offers many advantages, but also comes with challenges, says one expert.

Addition of Trilaciclib May Mitigate Myelosuppression in Patients With Small Cell Lung Cancer

June 28th 2019, 4:00pm

Video

Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, according to one expert.

Patients With Mantle Cell Lymphoma Experience Response to Imbruvica Combinations

June 27th 2019, 7:50pm

Article

Newer treatments for MCL offer hope to patients living with the fast-growing and challenging-to-treat disease.

Targeted Therapies for Advanced MCL May Improve Outcomes as Front-line Treatment

June 26th 2019, 8:00pm

Video

Mantle cell lymphoma remains incurable, despite researchers’ best efforts. However, new treatment options show promise in the relapsed/refractory setting and may improve patient outcomes if moved to the front-line, according to Dr. Reem Karmali.